A novel dendritic cell subset involved in tumor immunosurveillance

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature Medicine

• Publication date

  2006-01-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm1356PMID 16444265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow.

  2005cited by this paper
• Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance.

  2005cited by this paper
• Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia.

  2004cited by this paper
• TRAIL and its receptors as targets for cancer therapy

  2004cited by this paper
• Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.

  2004cited by this paper
• NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer

  2004cited by this paper
• In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment.

  2003cited by this paper
• Nature's TRAIL--on a path to cancer immunotherapy.

  2003cited by this paper
• CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells.

  2002cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

  2001cited by this paper
• Identification of Tumor-Infiltrating Macrophages as the Killers of Tumor Cells After Immunization in a Rat Model System1

  2001cited by this paper
• IFN-γinduces cell death in human hepatoma cells through a trail/death receptor-mediated apoptotic pathway

  2001cited by this paper
• Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

  2001cited by this paper
• Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets.

  2001cited by this paper
• Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis

  2001cited by this paper
• IFN‐γinduces cell death in human hepatoma cells through a trail/death receptor‐mediated apoptotic pathway

  2001cited by this paper
• A Subset of Cytolytic Dendritic Cells in Rat1

  2000cited by this paper
• Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells.

  2000cited by this paper
• Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-γ Production by Dendritic Cells1

  2000cited by this paper
• Measles Virus Induces Functional TRAIL Production by Human Dendritic Cells

  2000cited by this paper
• Interleukin 12–dependent Interferon γ Production by CD8α+Lymphoid Dendritic Cells

  1999cited by this paper
• Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice

  1998cited by this paper
• Murine Macrophages Secrete Interferon γ upon Combined Stimulation with Interleukin (IL)-12 and IL-18: A Novel Pathway of Autocrine Macrophage Activation

  1998cited by this paper
• Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.

  1998cited by this paper
• TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.

  1997cited by this paper
• The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I

  1994cited by this paper
• Viral inhibition of inflammation. Cowpox virus encodes an inhibitor of the interleukin 1β converting enzyme.

  1992cited by this paper
• Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme.

  1992cited by this paper

• Mon4 as a novel monocyte subset with distinct profile and predictor of poor outcomes in individuals with myocardial infarction

  2025cites this paper
• Immunity from NK Cell Subsets Is Important for Vaccine-Mediated Protection in HPV+ Cancers

  2024cites this paper
• Characterization of tumoricidal activities mediated by a novel immune cell regimen composing interferon-producing killer dendritic cells and tumor-specific cytotoxic T lymphocytes

  2024cites this paper
• Predictive biomarkers and initial analysis of maternal immune alterations in postpartum preeclampsia reveal an immune-driven pathology

  2024cites this paper
• Biological characteristics and immune responses of NK Cells in commonly used experimental mouse models

  2024cites this paper
• Potential role of immunotherapy and targeted therapy in the treatment of cancer: A contemporary nursing practice

  2024cites this paper
• GSK-3β in Dendritic Cells Exerts Opposite Functions in Regulating Cross-Priming and Memory CD8 T Cell Responses Independent of β-Catenin

  2024cites this paper
• Nanomedicine-induced programmed cell death enhances tumor immunotherapy

  2023cites this paper
• Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity

  2023cites this paper
• Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy

  2023cites this paper
• OMIP‐095: 40‐Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues

  2023cites this paper
• Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors

  2023cites this paper
• Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing Receptors

  2022cites this paper
• TREM1+ regulatory myeloid cells expand in steatohepatitis-HCC and associate with poor prognosis and therapeutic resistance to immune checkpoint blockade

  2022cites this paper
• Phenotypical Diversification of Early IFNα-Producing Human Plasmacytoid Dendritic Cells Using Droplet-Based Microfluidics

  2021cites this paper
• Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL‐expressing plasmacytoid dendritic cells in mice

  2020cites this paper
• T-bet transduction enhances anti-tumor efficacy of IFN-producing dendritic cell (IKDC) against hepatocellular carcinoma via apoptosis induction.

  2020cites this paper
• IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18

  2020cites this paper
• Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling.

  2020cites this paper
• How does autophagy affect tumor-infiltrating immune cells?

  2020cites this paper
• Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis

  2020cites this paper
• An Erg-driven transcriptional program controls B cell lymphopoiesis

  2020cites this paper
• Imatinib modulates pro-inflammatory microenvironment with angiostatic effects in experimental lung carcinogenesis

  2019cites this paper
• Evaluation of the Cell Death Induction of Gold Nanoparticles Conjugated Antibodies Produced Against a Small Epitope of DR5 Protein in MCF7 Cells

  2019cites this paper
• Glycolipid Stimulation of Invariant NKT Cells Expands a Unique Tissue-Resident Population of Precursors to Mature NK Cells Endowed with Oncolytic and Antimetastatic Properties

  2019influential citation
• The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses

  2019cites this paper
• Cyclophosphamide, Fluorouracil and subcutaneous Interleukin-2 in the treatment of advanced GIST: A Case Report

  2019cites this paper
• Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model

  2019cites this paper
• Natural killer cells limit the clearance of senescent lung adenocarcinoma cells

  2019cites this paper
• CRTAM+ NK cells endowed with suppressor properties arise in leukemic bone marrow

  2019cites this paper
• Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy

  2019cites this paper
• An Erg driven transcriptional program controls B-lymphopoiesis

  2019cites this paper
• IL-15 Generates IFN-γ-producing Cells Reciprocally Expressing Lymphoid-Myeloid Markers during Dendritic Cell Differentiation

  2019cites this paper
• Cancer stem cells-driven tumor growth and immune escape: the Janus face of neurotrophins

  2019cites this paper
• Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results

  2019cites this paper
• Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific

  2018cites this paper
• Porcine NK cells display features associated with antigen‐presenting cells

  2018cites this paper
• The Secrets of T Cell Polarization

  2018cites this paper
• The 46th David A. Karnofsky Memorial Award Lecture: Oligometastasis-From Conception to Treatment.

  2018cites this paper
• Impact d’une infection par le virus grippal de type A sur la myélopoïèse

  2018cites this paper
• Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma

  2018cites this paper
• Regulatory IFN‐γ‐producing killer dendritic cells are enhanced in B6.MLR‐Faslpr/J lupus‐prone mice

  2018cites this paper
• Activity of Unpulsed Dendritic Cells Dendritic Cells Account for the Tumoricidal Bone Marrow-Derived IFN-Producing Killer

  2017influential citation
• Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis.

  2017cites this paper
• Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma

  2017cites this paper
• Radiotherapy and immunotherapy: a beneficial liaison?

  2017cites this paper
• Granzyme/Perforin-Dependent Mechanism Cells through an NKG2D- and Macrophages Kill Tumor + CD8 + Rat CD4

  2017influential citation
• Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity

  2017cites this paper
• Tumor abolition and antitumor immunostimulation by physico-chemical tumor ablation.

  2017cites this paper
• Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

  2017cites this paper
• The Role of the Nucleosome Remodeling Factor NURF in Inhibiting T and Natural Killer Cell Mediated Antitumor Immunity by Suppressing Tumor Antigenicity and Natural Cytotoxicity Receptor Co-ligands

  2017cites this paper
• of the Radboud University Nijmegen

  2017cites this paper
• HSPs - Ambiguous Mediators of Immunity

  2017influential citation
• The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion

  2017cites this paper
• Early Differentiation of Human CD11c+NK Cells with γδ T Cell Activation Properties Is Promoted by Dialyzable Leukocyte Extracts

  2016cites this paper
• Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model

  2016cites this paper
• A role for pre-mNK cells in tumor progression

  2016influential citation
• Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity

  2016cites this paper
• Resistance of novel mouse strains different in MHC class I and the NKC domain to the development of experimental tumors.

  2016cites this paper
• CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model.

  2016cites this paper
• Immunological off-target effects of imatinib

  2016cites this paper
• Die Bedeutung der Zelltodinduktion bei der in vitro Interaktion von MDSCs und T-Zellen

  2016cites this paper
• Human γδ T cell-based immunotherapy for breast cancer

  2015cites this paper
• Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies.

  2015cites this paper
• Expansion of an Atypical NK Cell Subset in Mouse Models of Systemic Lupus Erythematosus

  2015cites this paper
• « Une nouvelle cellule dendritique impliquée dans l'immunité anti-tumorale / Interferon- producing killer dendritic cells (IKDC) »

  2015influential citation
• NK Cell Subset Disease by Adoptive Transfer of an Atypical Cutting Edge: Induction of Inflammatory

  2015cites this paper
• Cutting Edge: Induction of Inflammatory Disease by Adoptive Transfer of an Atypical NK Cell Subset

  2015cites this paper
• Etude de la régulation transcriptionnelle des lymphocytes T CD4 dans un contexte de cancer : application en immunothérapie anticancéreuse

  2015cites this paper
• Perforin-Positive Dendritic Cells Exhibit an Immuno-regulatory Role in Metabolic Syndrome and Autoimmunity.

  2015cites this paper
• ErythematosusMouse Models of Systemic Lupus Expansion of an Atypical NK Cell Subset in

  2015cites this paper
• Depletion of B220+NK1.1+ cells enhances the rejection of established melanoma by tumor-specific CD4+ T cells

  2015cites this paper
• Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.

  2015cites this paper
• Étude moléculaire du TNF-Related Apoptosis Induced Ligand (TRAIL) et de l’activation du Toll-Like Receptor 7 (TLR7) dans les cellules dendritiques plasmacytoïdes lors de la réponse antivirale

  2015cites this paper
• Interactions between innate and adaptive lymphocytes

  2014cites this paper
• TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

  2014cites this paper
• Correction: Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

  2014cites this paper
• Trial watch: Dendritic cell-based anticancer therapy

  2014cites this paper
• Immunobiology of Dendritic Cells in Cancer

  2014cites this paper
• Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).

  2014cites this paper
• MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4+ T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion

  2014influential citation
• Nilotinib combined with interleukin-2 mediates antitumor and immunological effects in a B16 melanoma model.

  2014cites this paper
• Role of Mouse Innate Immunity in Immunodeficient Mice for Xenotransplantation

  2014cites this paper
• Flow Cytometric Detection of p38 MAPK Phosphorylation and Intracellular Cytokine Expression in Peripheral Blood Subpopulations from Patients with Autoimmune Rheumatic Diseases

  2014cites this paper
• Immunomodulatory effect of poly-γ-glutamic acid derived from Bacillus subtilis on natural killer dendritic cells.

  2014cites this paper
• Tumor-Induced Immune Suppression

  2014influential citation
• Gene Therapy with Beta-Defensin 2 Induces Antitumor Immunity and Enhances Local Antitumor Effects

  2014cites this paper
• Natural Killer Cells: The Secret Weapon in Dendritic Cell Vaccination Strategies

  2014cites this paper
• Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy.

  2013cites this paper
• Tumoricidal activity of human dendritic cells

  2013cites this paper
• for perforin, granzyme A, TREM-1, and TLR7 Deletion of cognate CD8 T cells by immature dendritic cells: a novel role

  2013cites this paper
• [Immune response and colorectal cancer].

  2013cites this paper
• An unconventional TRAIL to cancer therapy

  2013cites this paper
• Tumor Ablation

  2013cites this paper
• Immunomodulatory properties of probiotic bacteria

  2013cites this paper
• Modeling Leukocyte-Leukocyte Non-Contact Interactions in a Lymph Node

  2013cites this paper
• Interleukin-21 expanded NKDC in vitro reduces the B16F10 tumor growth in vivo.

  2013cites this paper
• The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering.

  2013cites this paper
• Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients

  2013cites this paper
• Réponse immunitaire et cancers colorectaux

  2013cites this paper